Stock comparison
Marksans Pharma Limited
MARKSANS.BO$117.28BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$106.55BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
MARKSANS.BO 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
MARKSANS.BO0wins
7winsSANOFICONR.NS
61C
B78
76B
A89
57D
B83
57D
B77
38F
A91
50D
A86
44F
A85
Side-by-side metrics
| Metric | MARKSANS.BO | SANOFICONR.NS |
|---|---|---|
| Market cap | Winner: $117.28B | $106.55B |
| P/E (TTM) | Winner: 27.1x | 44.2x |
| EV/EBIT | Winner: 18.9x | 31.8x |
| ROIC (TTM) | 13.03% | 59.15% Winner |
| Gross margin | 56.72% | 68.13% Winner |
| Net margin | 14.16% | 27.35% Winner |
| Revenue CAGR 5y | 16.85% | 27.01% Winner |
| EPS CAGR 5y | 12.88% | 20.67% Winner |
| Debt / Equity | 0.1x | 0.1x Winner |
| Dividend yield | - | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MARKSANS.BO leads on
- EV/EBIT18.9xvs 31.8x+41%
- P/E (TTM)27.1xvs 44.2x+39%
- Market cap$117.28Bvs $106.55B+9%
SANOFICONR.NS leads on
- ROIC (TTM)59.15%vs 13.03%+78%
- Net margin27.35%vs 14.16%+48%
- Debt / Equity0.1xvs 0.1x+43%
- EPS CAGR 5y20.67%vs 12.88%+38%
More like MARKSANS.BO
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.